Nektar Therapeutics | NKTR - Selling And Administration Expenses


Nektar Therapeutics reported $-0.18 in Selling and Administration Expenses for its fiscal quarter ending in September of 2024.





Selling And Administration Expenses Change Date
Agios Pharmaceuticals USD 41.27M 4.6M Sep/2025
ALKERMES USD 171.77M 17.9M Sep/2025
Alterity Therapeutics Limited AUD 2.29M 649.1K Jun/2023
Amgen USD 1.94B 237M Dec/2025
Baxter International USD 708M 10M Sep/2025
BioCryst Pharmaceuticals USD 80.47M 15.39M Dec/2024
Biogen USD 545.2M 38.6M Sep/2025
Bristol-Myers Squibb USD 2.18B 392M Dec/2025
Cara Therapeutics USD 4.64M 2.19M Mar/2025
Cipla INR 13.25B 101.8M Dec/2025
Dr.Reddys Laboratories INR 26.92B 482M Dec/2025
Eisai JPY 111.72B 7.86B Dec/2025
Eli Lilly USD 3.13B 391.3M Dec/2025
Esperion Therapeutics USD 39.98M 4.21M Sep/2024
Exelixis USD 123.02M 19.9M Dec/2025
Gilead Sciences USD 1.78B 425M Dec/2025
GlaxoSmithKline GBP 2.68B 518M Dec/2025
Grifols EUR 333.1M 157M Sep/2025
Halozyme Therapeutics USD 37.53M 4.53M Sep/2025
Incyte USD 390.41M 61.33M Dec/2025
Ionis Pharmaceuticals USD 86.56M 4.04M Sep/2025
Ironwood Pharmaceuticals USD 33.33M 2.78M Dec/2024
Karyopharm Therapeutics USD 27.19M 442K Dec/2024
MacroGenics USD 9.9M 600K Sep/2025
Merck USD 2.85B 215M Dec/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Neurocrine Biosciences USD 291.6M 5.3M Sep/2025
Novartis USD 3.31B 134M Sep/2025
Pfizer USD 4.08B 894M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sarepta Therapeutics USD 77.11M 7.22M Sep/2025
Takeda JPY 282.78B 29.23B Dec/2025
Teva Pharmaceutical Industries USD 1.12B 147M Dec/2025
Xencor USD 87.78M 72.66M Sep/2025